Low-dose methotrexate to treat mycosis fungoides: a retrospective study in 69 patients (Q35567170)

8 August 2017

title

Low-dose methotrexate to treat mycosis fungoides: a retrospective study in 69 patients (English)

1 reference

8 August 2017

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(03)01591-3

24 March 2024

author name string

Mohammed Kashani-Sabet

series ordinal

1 reference

8 August 2017

Alex McMillan

series ordinal

1 reference

8 August 2017

Herschel S. Zackheim

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14576667

24 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S0190962203015913?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0190-9622(03)01591-3

https://api.elsevier.com/content/article/PII:S0190962203015913?httpAccept=text/plain

24 March 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0190-9622(03)01591-3

Journal of the American Academy of Dermatology

24 March 2024

published in

1 reference

8 August 2017

1 reference

8 August 2017

1 reference

8 August 2017

page(s)

873-878

1 reference

OBSERVATIONS ON THE USE OF CANCER CHEMOTHERAPEUTIC AGENTS IN PATIENTS WITH MYCOSIS FUNGOIDES.

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901591-3

7 January 2021

Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: results in twenty-nine patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901591-3

7 January 2021

Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901591-3

7 January 2021

Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901591-3

7 January 2021

Topical corticosteroids for mycosis fungoides. Experience in 79 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901591-3

7 January 2021

Mycosis fungoides: management with topical nitrogen mustard

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901591-3

7 January 2021

Topical carmustine (BCNU) for cutaneous T cell lymphoma: a 15-year experience in 143 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901591-3

7 January 2021

Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901591-3

7 January 2021

The pharmacology of methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901591-3

7 January 2021

Management of oral mucositis associated with cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901591-3

7 January 2021

Short-term methotrexate therapy in psoriasis: a study of 197 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901591-3

7 January 2021

Trimetrexate in relapsed T-cell lymphoma with skin involvement.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901591-3

7 January 2021

Identifiers

DOI

1 reference

8 August 2017

1 reference